ascendis pharma glp-1 receptor agonist Ozempic maker Novo Nordisk is working on a once-monthly weight-loss drug A schematic overview of GLP-1

Learn why semaglutide & tirzepatide slow digestion, and discover lifestyle tips + Digest by Strive for natural, lasting relief.

With the participation of researchers from the Paul Langerhans Institute Dresden (PLID), partner at the German Center for Diabetes Research, a GLP-1 receptor agonist in the form of tablets could for the first time be compared with the most common second-line therapy of T2D, a DPP-IV inhibitor

Thats why weve created Youtheory GLP-1 Support 2x Action Probiotic to help ease those digestive discomforts and get you back on your regular schedule.*

Todays DietitianVol

Find out everything about this - if its true and worth all the hype.

Here is what patients should know.